NEW YORK, July 18 (GenomeWeb News) - Genaissance Pharmaceuticals and Organon will jointly study genetic markers related to drug response in certain undisclosed psychiatric disorders, and plan to develop diagnostics based on the resulting data, the companies said today.

 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.